TriSalus Life Sciences Q3 EPS $(0.15) Misses $(0.13) Estimate, Sales $12.900M Miss $14.024M Estimate
Benzinga Newsdesk 12 hours ago
NewsEarningsEarnings Misses
TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 84.38 percent increase over losses of $(0.96) per
TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 84.38 percent increase over losses of $(0.96) per share from the same period last year. The company reported quarterly sales of $12.900 million which missed the analyst consensus estimate of $14.024 million by 8.01 percent. This is a 11.53 percent increase over sales of $11.566 million the same period last year.